Chung Yong-ji is a South Korean businessman and the founder and CEO of Caregen (KOSDAQ: 214370), a leading biotechnology company specializing in peptide technology and its application in cosmetics and anti-wrinkle solutions. Born in 1970, his background is rooted in elite scientific education and technological precision.

Chung received advanced degrees, including a Bachelor of Science (B.S.) from Sungkyunkwan University, a Master of Science (M.S.) from the University of Texas at San Antonio, and a PhD from Cornell University. This extensive, high-level scientific and academic training provided him with the crucial expertise to launch a deep-tech biotech company focused on creating proprietary, anti-aging solutions.

Chung Yong-ji founded Caregen in August 2001, driven by his commitment to specialized peptide technology research and development. His strategic vision was to position Caregen at the absolute cutting edge of biotechnology, focusing on creating proprietary peptides that could be used for medical-grade aesthetic and anti-aging treatments.

Under his leadership as CEO, Caregen successfully went public on the KOSDAQ in 2015, raising approximately $160 million and securing Chung's multi-billion dollar fortune. The company's success is built on its mastery of growth factors and biomimetic peptides, which are essential ingredients in anti-wrinkle shots and cosmetic formulations. Chung maintains a massive 64 percent controlling stake in the company, ensuring the long-term, R&D-heavy strategy continues to drive growth in the lucrative global beauty and wellness market.

Chung Yong-ji's social impact is structural, stemming from Caregen's role in advancing the field of peptide technology and medical aesthetics. His company's products are essential to the global beauty and wellness industry, providing new solutions for cosmetic and anti-aging treatments.

His personal philanthropy often supports scientific research and education, reflecting his background as a scholar who holds a PhD from Cornell University. His commitment to R&D excellence drives technological progress in the highly competitive global biotech sector.

Chung Yong-ji maintains the professional, intellectual style of a South Korean biotech executive. His attire is consistently formal and high-quality, favoring tailored business suits, reflecting his extensive academic background and high-level corporate authority. His aesthetic is one of composed, scientific confidence.

Residing in South Korea, his luxury is the profound security and autonomy derived from his multi-billion dollar fortune, which is rooted in a deep-tech, specialized industry. His life is defined by his commitment to scientific rigor and his successful translation of peptide research into immense commercial value.